Novel insights into the synergistic interaction of a thioredoxin reductase inhibitor and TRAIL: the activation of the ASK1-ERK-Sp1 pathway. [electronic resource]
Producer: 20131223Description: e63966 p. digitalISSN:- 1932-6203
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cyclodextrins -- pharmacology
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Female
- Flavonoids -- pharmacology
- Humans
- MAP Kinase Kinase Kinase 5 -- metabolism
- Phosphorylation -- drug effects
- Protein Binding -- drug effects
- Receptors, TNF-Related Apoptosis-Inducing Ligand -- genetics
- Signal Transduction -- drug effects
- Sp1 Transcription Factor -- metabolism
- TNF-Related Apoptosis-Inducing Ligand -- pharmacology
- Thioredoxin-Disulfide Reductase -- antagonists & inhibitors
- Thioredoxins -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
There are no comments on this title.
Log in to your account to post a comment.